And, it may very well turn out to be all generic makers of statins, or perhaps, Astra Zeneca PLC, and its Crestor. Could it be?
We'll see. Cheers!
Thursday, April 10, 2008
Unlikely Potential Winner Emerges from Vytorin Collapse. . . .
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment